MASS908 Devices Inc
$8.85
$0.27
(3.15%)
EarningsAug 4
Mkt Cap$324.44M
Vol768,956.00
Fundamentals
908 Devices (MASS) Upgraded to Buy: Here's Why
908 Devices (MASS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
908 Devices Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced that on June 1, 2026, the Compensation Committee of its Board of Directors granted options to four new...
Business Wire
908 Devices to Present at the 16th Annual East Coast IDEAS Investor Conference
908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced that CEO and Co-founder Kevin J. Knopp and CFO Joe Griffith will present and host investor meetings at the...
Business Wire
908 Devices Q1 Earnings Call Highlights
908 Devices (NASDAQ:MASS) reported first-quarter 2026 revenue of $13.4 million, up 14% year over year, as the company pointed to continued momentum in U.S. state and local demand and announced a new acquisition aimed at expanding its handheld narcotics detection portfolio and recurring revenue base...
MarketBeat
908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates
908 Devices (MASS) delivered earnings and revenue surprises of 0.00% and +1.66%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook
908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported...
Business Wire
908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio
908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has completed the acquisition of NIRLAB AG, a privately held company based in...
Business Wire
908 Devices (MASS) Projected to Post Earnings on Wednesday
908 Devices (NASDAQ:MASS) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at...
MarketBeat
908 Devices to Report First Quarter 2026 Financial Results on May 6, 2026
908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will report financial results for the first quarter 2026 before market open on Wednesday, May 6, 2026...
Business Wire
908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces the appointment of Kola Otitoju as its Chief Business & Strategy Officer, a newly created executive position. Mr. Otitoju will oversee product and corporate strategy, business development...
Business Wire
<
1
2
...
>